1. Academic Validation
  2. Cyclophilin inhibitors as antiviral agents

Cyclophilin inhibitors as antiviral agents

  • Bioorg Med Chem Lett. 2013 Aug 15;23(16):4485-92. doi: 10.1016/j.bmcl.2013.05.101.
Michael Peel 1 Andrew Scribner
Affiliations

Affiliation

  • 1 SCYNEXIS Inc., Research Triangle Park, NC 27709, USA. mike.peel@scynexis.com
Abstract

Cyclophilins (Cyps) are ubiquitous proteins that effect the cis-trans isomerization of Pro amide bonds, and are thus crucial to protein folding. CypA is the most prevalent of the ~19 human Cyps, and plays a crucial role in viral infectivity, most notably for HIV-1 and HCV. Cyclophilins have been shown to play key roles in effective replication of a number of viruses from different families. A drug template for CypA inhibition is cyclosporine A (CsA), a cyclic undecapeptide that simultaneously binds to both CypA and the CA(2+)-dependent phosphatase Calcineurin (CN), and can attenuate immune responses. Synthetic modifications of the CsA scaffold allows for selective binding to CypA and CN separately, thus providing access to novel, non-immunosuppressive Antiviral agents.

Keywords

Antiviral; Cyclophilin; Cyclosporine; HIV; Hepatitis C; Immunosuppression.

Figures
Products